The Binding of Pirenzepine to Digitonin-solubilized Muscarinic Acetylcholine Receptors from the Rat Myocardium

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1986 Feb 1

PMID 3754173

Citations 5

Authors

N J Birdsall

E C Hulme

M Keen

Affiliations

Soon will be listed here.

Abstract

The binding of pirenzepine to digitonin-solubilized rat myocardial muscarinic acetylcholine receptors has been examined at 4 degrees C. Solubilization produced only small changes in the binding of N-methylscopolamine and atropine. In contrast to the low affinity binding of pirenzepine found to be present in in the membranes, high affinity binding was detected in the soluble preparation. In both preparations, pirenzepine binding was complex. High affinity pirenzepine binding (KD approximately 3 X 10(-8)M) to the soluble myocardial receptors could be monitored directly using [3H]-pirenzepine. [3H]-pirenzepine-labelled soluble myocardial receptors have a sedimentation coefficient of 11.1 s. This indicates that [3H]-pirenzepine binds predominantly to the uncoupled form of the receptor. However, [3H]-pirenzepine-agonist competition experiments indicated that the high affinity pirenzepine binding sites are capable of coupling with a guanosine 5'-triphosphate (GTP)-binding protein. Pirenzepine affinities for the soluble myocardial receptors were unaffected by their state of association with the GTP-binding proteins found in the heart. The equilibrium binding properties of the soluble cortical and myocardial receptors were very similar. However, the binding kinetics of the myocardial receptor were much slower. It appears that the membrane environment can affect the affinity of pirenzepine for the rat myocardial muscarinic receptor. Removal of the constraint by solubilization allows the expression of high affinity pirenzepine binding.

Citing Articles

Molecular properties of muscarinic acetylcholine receptors.

Haga T Proc Jpn Acad Ser B Phys Biol Sci. 2013; 89(6):226-56.

PMID: 23759942 PMC: 3749793. DOI: 10.2183/pjab.89.226.

Relating surfactant properties to activity and solubilization of the human adenosine a3 receptor.

Berger B, Garcia R, Lenhoff A, Kaler E, Robinson C Biophys J. 2005; 89(1):452-64.

PMID: 15849244 PMC: 1366546. DOI: 10.1529/biophysj.104.051417.

Direct binding studies on ileal and cardiac muscarinic receptors.

Michel A, Whiting R Br J Pharmacol. 1987; 92(4):755-67.

PMID: 3427279 PMC: 1853717. DOI: 10.1111/j.1476-5381.1987.tb11379.x.

Radioligand binding characteristics of the chicken cardiac muscarinic receptor.

Michel A, Whiting R Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(3):279-84.

PMID: 2812039 DOI: 10.1007/BF00168511.

Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes.

Pedder E, Eveleigh P, Poyner D, Hulme E, Birdsall N Br J Pharmacol. 1991; 103(2):1561-7.

PMID: 1884110 PMC: 1908365. DOI: 10.1111/j.1476-5381.1991.tb09827.x.

References

Birdsall N, BURGEN A, Hulme E . The binding of agonists to brain muscarinic receptors. Mol Pharmacol. 1978; 14(5):723-36. View

Berrie C, Birdsall N, Dadi H, Hulme E, Morris R, Stockton J . Purification of the muscarinic acetylcholine receptor from rat forebrain. Biochem Soc Trans. 1985; 13(6):1101-3. DOI: 10.1042/bst0131101. View

Hammer R, Berrie C, Birdsall N, BURGEN A, Hulme E . Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980; 283(5742):90-2. DOI: 10.1038/283090a0. View

Brown D, Forward A, Marsh S . Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br J Pharmacol. 1980; 71(2):362-4. PMC: 2044477. DOI: 10.1111/j.1476-5381.1980.tb10948.x. View

Laduron P, Leysen J, Gorissen H . Muscarinic receptor: multiple sites or unitary concept?. Arch Int Pharmacodyn Ther. 1981; 249(2):319-21. View

Hulme E, Berrie C, Birdsall N, BURGEN A . Two populations of binding sites for muscarinic antagonists in the rat heart. Eur J Pharmacol. 1981; 73(2-3):137-42. DOI: 10.1016/0014-2999(81)90085-6. View

Burgisser E, De Lean A, Lefkowitz R . Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. Proc Natl Acad Sci U S A. 1982; 79(6):1732-6. PMC: 346054. DOI: 10.1073/pnas.79.6.1732. View

Hammer R . Subclasses of muscarinic receptors and pirenzepine. Further experimental evidence. Scand J Gastroenterol Suppl. 1982; 72:59-67. View

Barlow R, Chan M . The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea-pig ileum and rat fundus strip. Br J Pharmacol. 1982; 77(3):559-63. PMC: 2044615. DOI: 10.1111/j.1476-5381.1982.tb09331.x. View

10.

Watson M, Roeske W, Yamamura H . [3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. Life Sci. 1982; 31(18):2019-23. DOI: 10.1016/0024-3205(82)90041-8. View

11.

Hammer R, Giachetti A . Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 1982; 31(26):2991-8. DOI: 10.1016/0024-3205(82)90066-2. View

12.

Hulme E, Berrie C, Haga T, Birdsall N, BURGEN A, Stockton J . Solubilisation and molecular characterisation of muscarinic acetylcholine receptors. J Recept Res. 1983; 3(1-2):301-11. DOI: 10.3109/10799898309041943. View

13.

Watson M, Yamamura H, Roeske W . A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Life Sci. 1983; 32(26):3001-11. DOI: 10.1016/0024-3205(83)90652-5. View

14.

Birdsall N, Hulme E, Stockton J, BURGEN A, Berrie C, Hammer R . Muscarinic receptor subclasses: evidence from binding studies. Adv Biochem Psychopharmacol. 1983; 37:323-9. View

15.

Hulme E, Berrie C, Birdsall N, Jameson M, Stockton J . Regulation of muscarinic agonist binding by cations and guanine nucleotides. Eur J Pharmacol. 1983; 94(1-2):59-72. DOI: 10.1016/0014-2999(83)90442-9. View

16.

Watson M, Roeske W, Johnson P, Yamamura H . [3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia. Brain Res. 1984; 290(1):179-82. DOI: 10.1016/0006-8993(84)90751-0. View

17.

Venter J, Eddy B, Hall L, Fraser C . Monoclonal antibodies detect the conservation of muscarinic cholinergic receptor structure from Drosophila to human brain and detect possible structural homology with alpha 1-adrenergic receptors. Proc Natl Acad Sci U S A. 1984; 81(1):272-6. PMC: 344654. DOI: 10.1073/pnas.81.1.272. View

18.

Roeske W, Venter J . The differential loss of [3H]pirenzepine vs [3H] (-) quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor. Biochem Biophys Res Commun. 1984; 118(3):950-7. DOI: 10.1016/0006-291x(84)91487-6. View

19.

Luthin G, Wolfe B . Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. J Pharmacol Exp Ther. 1984; 228(3):648-55. View

20.

Berrie C, Birdsall N, Haga K, Haga T, Hulme E . Hydrodynamic properties of muscarinic acetylcholine receptors solubilized from rat forebrain. Br J Pharmacol. 1984; 82(4):839-51. PMC: 1986934. DOI: 10.1111/j.1476-5381.1984.tb16481.x. View